REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bio Preventive Medicine Corp. (Taiwan, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Bio Preventive Medicine Corp. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Bio Preventive Medicine Corp. is a biotechnology research, development and testing service company, focusing on products for early disease detection and prevention. The company was founded in 2014 and is headquartered in Taiwan.

Headquarters
6F-1, No. 18 Taiyuan St, Zhubei City
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Bio Preventive Medicine Corp. report to view the information.

Website: http://www.bpmbiotech.com

Basic Information
Total Employees:
Purchase the Bio Preventive Medicine Corp. report to view the information.
Outstanding Shares:
Purchase the Bio Preventive Medicine Corp. report to view the information.
Financial Auditors:
Purchase the Bio Preventive Medicine Corp. report to view the information.
Incorporation Date:
June 25, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Finance Officer
Ownership Details
Purchase this report to view the information.
5.01%
Purchase this report to view the information.
0.43%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bio Preventive Medicine Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
133.06%▲
Total operating revenue
153.19%▲
Operating profit (EBIT)
-16.71%▼
EBITDA
-24.69%▼
Net Profit (Loss) for the Period
-19.32%▼
Total assets
-7.39%▼
Total equity
-45%▼
Operating Profit Margin (ROS)
2435.38%▲
Net Profit Margin
2387.73%▲
Return on Equity (ROE)
-23.14%▼
Debt to Equity Ratio
50.7%▲
Quick Ratio
-6.99%▼
Cash Ratio
-6.45%▼

Similar companies

Syngen Biotech Co., Ltd.
 
DV Biomed Co., Ltd.
CH Biotech R&D Co., Ltd.
 
Medigen Biotechnology Corporation
EirGenix Inc.
 
Glac Biotech Co., Ltd. (Tainan City) (丰华生物科技 (台南市))
Senhwa Biosciences, Inc.
 
TWI Biotechnology, Inc.
Metagone Biotech Inc.
 
Global BioPharma, Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo